#4 - Howie Lempel on pandemics that kill hundreds of millions and how to stop them

Context and Scope of Risk

• Pandemics are identified as one of the most probable causes of future global catastrophic risk, with Bill Gates estimating that a pandemic is the most likely event to kill over 10 million people in the coming decades.
• The potential severity of a natural pandemic is illustrated by the 1918 Spanish Flu, which killed 3–5% of the global population (100–200 million people at the time), suggesting a modern equivalent could kill 200–300 million.
• A worst-case scenario involving a pathogen engineered for high lethality (e.g., 40–50% fatality rate) combined with high transmissibility could theoretically result in 25% (approx. 2 billion) of the global population dying.
• Man-made biological risks are considered potentially more severe than natural ones in the long run due to the increasing accessibility of synthetic biology and the possibility of intentional weaponization.
• There is a significant gap between government spending on general public health and spending on specific interventions to prevent "global catastrophic" pandemics, such as policy advocacy and long-term strategic planning.

Current Response Infrastructure and Gaps

• Disease surveillance relies heavily on "guess-and-test" diagnostics; broad-spectrum diagnostics that can identify unknown pathogens in a single sample are largely unavailable.
• The World Health Organization (WHO) has an outbreak alert and response team, but it is severely under-resourced and lacks the capacity to deploy a rapid, coordinated strike team immediately upon notification.
• International Health Regulations (IHR) are often not complied with by nations due to the high costs of compliance and the fear of economic stigma, travel bans, and trade restrictions.
• Response coordination is often fragmented, relying on ad-hoc contributions from NGOs (e.g., Doctors Without Borders) and voluntary aid from wealthy nations rather than a standing, automatic international mechanism.
• Data sharing regarding pathogen sequencing and vaccine ownership is frequently negotiated on a crisis-by-crisis basis, causing critical delays.

Specific Interventions and Grant Strategies

• Open Philanthropy funded a Blue Ribbon Panel on Biodefense (grant of ~$300,000) to convene policymakers in Washington D.C., which successfully secured meetings with Vice President Biden and spurred congressional hearings.
• A grant was awarded to the iGEM competition to support a safety and security team, training students in synthetic biology on security culture and safe handling of organisms.
• Current grant strategies prioritize "neglectedness" and "tractability," focusing on areas where philanthropy can make a difference that governments cannot, such as political advocacy and long-term catastrophic risk planning.
• Advocacy is seen as crucial to holding governments accountable and subsidizing work on low-probability, high-impact scenarios that fall outside standard short-term government budget cycles.

Policy and Security Recommendations

• Non-proliferation regimes based on lists of banned pathogens are becoming obsolete as synthetic biology advances; future security must address "information-only" threats where pathogens can be synthesized from digital sequences.
• There is a need for international coordination on "medical countermeasures" (vaccines, diagnostics, treatments) to overcome the lack of private sector incentives for low-probability threats.
• "Gain-of-function" research, which modifies pathogens to increase transmissibility or virulence for research purposes, requires a high barrier of proof regarding benefits before approval due to accident risks.
• Security culture and norms must be cultivated within the "DIY bio" and synthetic biology communities to ensure safety is prioritized over speed, as physical security measures (e.g., airport screenings) will be ineffective against digitized biological threats.
• Governments need to move beyond preparing for the "last epidemic" (reactive) toward preparing for novel, unknown threats (proactive), including developing rapid-response diagnostic platforms and flexible vaccine manufacturing.

Career Paths and Educational Opportunities

• The field is highly interdisciplinary, requiring expertise in epidemiology, microbiology, synthetic biology, social science, law, international relations, and data science.
• Recommended degrees include PhDs in epidemiology, synthetic biology, or medical fields, with an emphasis on interdisciplinary networking to bridge silos between health and security experts.
• Key academic and research institutions highlighted include Harvard, Stanford, MIT, UCSF, Emory University (due to proximity to CDC), and University of Nebraska at Omaha (focus on rare infectious diseases).
• Notable experts and labs mentioned for networking include Kevin Esvelt (MIT), George Church (Harvard), Drew Endy (Stanford), and the Center for Health Security at Johns Hopkins.
• Potential employers for early-career professionals include government agencies (CDC, DARPA, IARPA, BARDA, Defense Threat Reduction Agency), think tanks (Center for Health Security, Chatham House), and biotech startups focused on rapid countermeasure development.
• The "Emerging Leaders in Biosecurity Program" run by the Center for Health Security is highlighted as a key networking and entry point for early-career professionals.

Forward-Looking Statements and Challenges

• Maintaining "slack" vaccine production capacity or waiting scientists is considered politically unsustainable; the preferred solution is investing in research to drastically reduce the time required to design and manufacture countermeasures.
• The field lacks sufficient policy research to determine the optimal regulatory approaches for synthetic biology, requiring significant "pie-in-the-sky" theoretical work to anticipate future scenarios.
• There is a recognized need for better data utilization (e.g., electronic health records, search trends) for early outbreak detection, despite past failures of some predictive models like Google Flu Trends.
• Working in biosecurity offers transferable skills in biotech, global health, and security, though deep specialization in one area may require conscious effort to maintain breadth across disciplines.